Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Decoding gene expression heterogeneity in Triple Negative Breast Cancer [bulk RNA-seq]

ABSTRACT: Decoding gene expression heterogeneity in Triple Negative Breast Cancer [bulk RNA-seq]

PROVIDER: PRJNA1106811 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28863231.fastq.gz	Fastqsanger.gz
	SRR28863232.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Decoding gene expression heterogeneity in Triple Negative Breast Cancer

Project description:Decoding gene expression heterogeneity in Triple Negative Breast Cancer

| PRJNA1106798 | ENA

Decoding gene expression heterogeneity in Triple Negative Breast Cancer [scRNA-seq]

Project description:Decoding gene expression heterogeneity in Triple Negative Breast Cancer [scRNA-seq]

| PRJNA1106806 | ENA

Heterogeneity of triple-negative breast cancer

Project description:Heterogeneity of triple-negative breast cancer was examined and compared across morphologic and molecular features

2018-01-01 | GSE97342 | GEO

Transcriptional heterogeneity among MDA-MBA-468 triple-negative breast cancer cells

Project description:Intratumoral heterogeneity has been described for various tumor types and models of human cancer, and can have profound effects on tumor progression and drug resistance. This study describes transcriptional heterogeneity among subclonal populations (SCPs) derived from a single triple-negative breast cancer cell line.

2022-01-12 | GSE184542 | GEO

Decoding gene expression heterogeneity in Triple Negative Breast Cancer [bulk RNA-seq]

Project description:In this study, we have employed both bulk RNA- and sc-RNA-seq to investigate the transcriptional status of TNBC cells, grown as 2D or 3D cultures, prior and after development of resistance to two widely used chemotherapeutic drugs, paclitaxel and doxorubicin. Our aim was to uncover the gene expression programs that support drug tolerance in treatment-naïve cells and drug resistance in heterogeneous chemoresistant populations. Analysis of the data from the two techniques yielded similar results to a large degree, yet several low abundance gene expression changes in the chemoresistant cells were detected only by scRNA-seq.

2024-07-17 | GSE266354 | GEO

Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer

Project description:Epigenetic heterogeneity and transcriptional drivers of triple-negative breast cancer

| PRJNA837247 | ENA

Transcriptional heterogeneity among subclonal populations of MDA-MBA-468 triple-negative breast cancer cells

2022-01-12 | GSE184540 | GEO

MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer

Project description:Triple-negative breast cancer (TNBC) patients have a poor prognosis and few treatment options. Mouse models of TNBC are important for development of new therapies, however, few mouse models represent the complexity of TNBC. Here, we develop a female TNBC murine model by mimicking two common TNBC mutations with high co-occurrence: amplification of the oncogene MYC and deletion of the tumor suppressor PTEN. This Myc;Ptenfl model develops heterogeneous triple-negative mammary tumors that display histological and molecular features commonly found in human TNBC. Our research involves deep molecular and spatial analyses on Myc;Ptenfl tumors including bulk and single-cell RNA-sequencing, and multiplex tissue-imaging. Through comparison with human TNBC, we demonstrate that this genetic mouse model develops mammary tumors with differential survival and therapeutic responses that closely resemble the inter- and intra-tumoral and microenvironmental heterogeneity of human TNBC, providing a pre-clinical tool for assessing the spectrum of patient TNBC biology and drug response.

2022-10-17 | GSE215071 | GEO

MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer

2023-07-18 | GSE215070 | GEO

Transcriptional heterogeneity among MDA-MBA-468 triple-negative breast cancer cells

Project description:Transcriptional heterogeneity among MDA-MBA-468 triple-negative breast cancer cells

| PRJNA765012 | ENA